| LP248939-3 | LCDS v3.00 - Swallowing/nutritional status | COMPONENT | 1 |
| LP248940-1 | LCDS v3.00 - Special treatments, procedures, and programs - admission | COMPONENT | 1 |
| LP248941-9 | Kidney Failure Risk Equation | METHOD | 3 |
| LP248942-7 | Kidney failure 2-year risk | COMPONENT | 1 |
| LP248943-5 | Kidney failure 5-year risk | COMPONENT | 1 |
| LP248944-3 | Kidney failure 2-year and 5-year risk panel | COMPONENT | 1 |
| LP248945-0 | LCDS v3.00 - Assessment administration | COMPONENT | 1 |
| LP248947-6 | Signature of persons completing the assessment | COMPONENT | 1 |
| LP248948-4 | Signature | COMPONENT | 1 |
| LP248949-2 | LCDS v4.00 - Administrative information - admission | COMPONENT | 1 |
| LP248950-0 | LCDS v3.00 - Hearing, speech, and vision | COMPONENT | 1 |
| LP248951-8 | LCDS - Prior functioning: everyday activities | COMPONENT | 1 |
| LP248952-6 | Title of person collecting or coordinating collection of assessment information | COMPONENT | 1 |
| LP248953-4 | Signature of person collecting or coordinating collection of assessment information | COMPONENT | 1 |
| LP248955-9 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 3.00 | COMPONENT | 1 |
| LP248992-2 | Alpha pyrrolidinovalerophenone | COMPONENT | 3 |
| LP248993-0 | 4-Ethylmethcathinone | COMPONENT | 1 |
| LP248994-8 | 3,4-Dimethylmethcathinone | COMPONENT | 1 |
| LP248995-5 | LCDS v3.00 - Self-care - admission performance | COMPONENT | 1 |
| LP248996-3 | LCDS v3.00 - Self-care - discharge goal | COMPONENT | 1 |
| LP248997-1 | Pentedrone | COMPONENT | 1 |
| LP248998-9 | 4-Methylethcathinone | COMPONENT | 1 |
| LP248999-7 | Eutylone | COMPONENT | 3 |
| LP249000-3 | Pentylone | COMPONENT | 2 |
| LP249001-1 | LCDS v3.00 - Mobility - discharge goal during 3D assessment period | COMPONENT | 1 |
| LP249016-9 | LCDS v3.00 - Administrative information - discharge | COMPONENT | 1 |
| LP249017-7 | LCDS v4.00 - Bladder and bowel - planned discharge | COMPONENT | 1 |
| LP249018-5 | LCDS v3.00 - Self-care - discharge performance | COMPONENT | 1 |
| LP249019-3 | Bombay phenotype | COMPONENT | 3 |
| LP249020-1 | 60 min p max clot amplitude + heparinase | CHALLENGE | |
| LP249021-9 | Number of program interruptions | COMPONENT | 1 |
| LP249022-7 | LCDS v3.00 - Skin conditions - discharge | COMPONENT | 1 |
| LP249023-5 | LCDS v4.00 - Administrative information - expired | COMPONENT | 1 |
| LP249024-3 | LCDS v3.00 - Mobility - discharge performance during 3 day assessment period | COMPONENT | 1 |
| LP249031-8 | Cells.chromosome 3 monosomy | COMPONENT | |
| LP249032-6 | Streptococcus pneumoniae Danish serotype 1 | COMPONENT | |
| LP249033-4 | Streptococcus pneumoniae Danish serotype 1 Ab | COMPONENT | 2 |
| LP249034-2 | Streptococcus pneumoniae Danish serotype 1 IgG | COMPONENT | 5 |
| LP249035-9 | Streptococcus pneumoniae Danish serotype 12F | COMPONENT | |
| LP249036-7 | Streptococcus pneumoniae Danish serotype 12F Ab | COMPONENT | 4 |
| LP249037-5 | Streptococcus pneumoniae Danish serotype 12F IgG | COMPONENT | 5 |
| LP249038-3 | Streptococcus pneumoniae Danish serotype 14 | COMPONENT | |
| LP249039-1 | Streptococcus pneumoniae Danish serotype 14 Ab | COMPONENT | 2 |
| LP249040-9 | Streptococcus pneumoniae Danish serotype 14 IgG | COMPONENT | 5 |
| LP249041-7 | Streptococcus pneumoniae Danish serotype 17F IgG | COMPONENT | 2 |
| LP249042-5 | Streptococcus pneumoniae Danish serotype 17F Ab | COMPONENT | |
| LP249043-3 | Streptococcus pneumoniae Danish serotype 17F | COMPONENT | |
| LP249044-1 | Streptococcus pneumoniae Danish serotype 18F | COMPONENT | |
| LP249045-8 | Streptococcus pneumoniae Danish serotype 18F Ab | COMPONENT | |
| LP249046-6 | Streptococcus pneumoniae Danish serotype 18F IgG | COMPONENT | 2 |